Breast cancer in the elderly: Histological, hormonal and surgical characteristics

Breast

Volumn 16, Issue 1, 2007, Pages 60-67

  Pappo, I ^a   Karni, T ^a   Sandbank, J ^a   Dinur, I ^a   Sella, A ^a   Stahl Kent, V ^a   Wasserman, I ^a   Halevy, A ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Breast cancer; Elderly patients; Hormonal risk factors; Mastectomy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER GRADING; CANCER RISK; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GERIATRIC PATIENT; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MENARCHE; MENOPAUSE; METASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RISK FACTOR;

EID: 33846681318     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2006.05.007     Document Type: Article

References (30)

1. Statistical Abstract of the United States. Washington DC: Bureau of the Census; 1997.
2. Holmes C.E., and Muss H.B. Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin 53 (2003) 227-244
3. Jemal A., Siegel R., Ward E., Murray T., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
4. Goodwin J.S., Hunt W.C., Humble C.G., Key C.R., and Samer J.M. Cancer treatment protocols. Who gets chosen?. Arch Intern Med 148 (1988) 2258-2260
5. De Haes H., Curran D., Aaronson N.K., and Fentiman I.S. Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer 39 (2003) 945-951
6. Newschaffer C.J., Penberthy L., Desch C.E., Retchin S.M., and Whittemore M. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. Arch Intern Med 156 (1996) 85-90
7. Yoshinaga Y., Shirakusa T., Baba M., et al. Surgical treatment for elderly breast cancer patients over the age of 70. Int Surg 88 (2003) 169-174
8. Silliman R.A., Guadagnoli E., Rakowski W., et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol 20 (2002) 2680-2688
9. Rosen P.P., and Oberman H.A. Tumors of the mammary gland (1993), Armed Forces Institute of Pathology, Washington, DC
10. Sobin L.H., and Wittekind Ch. Breast tumors. In: Sobin L.H., and Wittekind Ch. (Eds). UICC TNM classification of malignant tumors. 6th ed (2000), Wiley-Liss, New York 131-141
11. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer: the value of histological grade in breast cancer. Histopathology 19 (1991) 403-410
12. Gazetas P., Estabrook A., O'Neil J., and Sciacca R. Importance of adequate staging and of hormone receptors in women older than age 70 with breast cancer. Ann Surg 216 (1992) 22-26
13. Grube B.J., Hansen N.M., Ye W., Herlong T., and Giuliano A.E. Surgical management of breast cancer in the elderly patient. Am J Surg 182 (2001) 359-364
14. Busch E., Kemeny M., Fremgen A., Osteen R.T., Winchester D.P., and Clive R.E. Patterns of breast cancer care in the elderly. Cancer 78 (1996) 101-111
15. Gajdos C., Tartter P.I., Bleiweiss I.J., Lopchinsky R.A., and Bernstein J.L. The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 192 (2001) 698-707
16. Diab S.G., Elledge R.M., and Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92 (2000) 550-556
17. Dowsett M, The ATAC Trialist Group. Analysis of time to recurrence in the ATAC Trial according to ER and PR status. The 26th annual San-Antonio breast cancer symposium, December 2003.
18. MacMahon B., Trichopoulos D., Brown J., et al. Age at menarche, urine estrogens and breast cancer risk. Int J Cancer 30 (1982) 427-431
19. Brinton L.A., Schairer C., Hoover R.N., and Fraumeni Jr. J.F. Menstrual factors and risk of breast cancer. Cancer Invest 6 (1988) 245-254
20. Tryggvadottir L., Tulinius H., Eyfjord J.E., and Sigurvinsson T. Breast cancer risk factors and age at diagnosis: an Icelandic cohort study. Int J Cancer 98 (2002) 604-608
21. Lagiou A., Lagiou P., Vassilarou D.S., Stoikidou M., and Trichopoulos D. Comparison of age at first full-term pregnancy between women with breast cancer and women with benign breast diseases. Int J Cancer 107 (2003) 817-821
22. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
23. De Haes J.C., Curran D., Aaronson N.K., and Fentiman I.S. Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer 39 (2003) 945-951
24. Solin L.J., Schultz D.J., and Fowble B.L. Ten-year results of the treatment of early stage breast carcinoma in elderly women using breast-conserving surgery and definitive breast irradiation. Int J Radiat Oncol Biol Phys 33 (1995) 45-51
25. Lazovich D.A., White E., Thomas D.B., and Moe R.E. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266 (1991) 3433-3438
26. Sandison A.J., Gold D.M., Wright P., and Jones P.A. Breast conservation or mastectomy: treatment choice of women aged 70 years and older. Br J Surg 83 (1996) 994-996
27. Bland K.I., Scott-Conner C.E., Menck H., and Winchester D.P. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 188 (1999) 586-595
28. Newlin M.E., Reiling R., and Nichols K. Necessity of axillary dissection in elderly women with early breast cancer. World J Surg 26 (2002) 1239-1242
29. Yoshinaga Y., Shirakusa T., Baba M., et al. Surgical treatment for elderly breast cancer patients over the age of 70. Int Surg 88 (2003) 169-174
30. Crivellari D., Price K., Gelber R.D., et al. International breast cancer study group. Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV. J Clin Oncol 21 (2003) 4517-4523